Secondary FMO references (that is, where FMO is not used as the main method/subject, or for some other reasons). 1. Y. Inadomi, T. Nakano, K. Kitaura, U. Nagashima, Increased Efficiency of Parallel Calculations of Fragment Molecular Orbitals by Using Fine-Grained Parallelization on a HITACHI SR8000 Supercomputer, Lecture Notes in Computer Science", Springer, Berlin, Vol. 2110, High-Performance Computing and Networking, Springer, Berlin, 2001, p. 569. 2. Y. Komeiji, Y. Inadomi, T. Nakano, PEACH 4 with ABINIT-MP: a general platform for classical and quantum simulations of biological molecules, Comput. Biol. Chem. 28 (2004) 155-161. 3. Increased Efficiency of Parallel Calculations of Fragment Molecular Orbitals by Using Fine-Grained Parallelization on a HITACHI SR8000 Supercomputer, Y. Inadomi, T. Nakano, K. Kitaura, U. Nagashima, in "Lecture Notes in Computer Science", Vol. 2110/2001, Springer, Berlin, 2004, p. 569. ISBN: 978-3-540-42293-8. 4. Electronic properties of DNA by DFT calculations based on fragment molecular orbital method, Y. Sengoku, M. Matsuoka, S.-I. Sugiki, S. Tanaka, N. Kurita, H. Sekino, J. Comput. Aided Chem. 5 (2004) 1-8. 5. Common Semiopen Conformations of Mg2+-Free Ras, Rho, Rab, Arf, and Ran Proteins Combined with GDP and Their Similarity with GEF-Bound Forms Mori, K.; Hata, M.; Neya, S.; Hoshino, T. J. Am. Chem. Soc. 127 (2005), 15127-15137. 6. Vitamin D Receptor: Ligand Recognition and Allosteric Network, K. Yamamoto, D. Abe, N. Yoshimoto, M. Choi, K. Yamagishi, H. Tokiwa, M. Shimizu, M. Makishima, and S. Yamada, J. Med. Chem. 49 (2006) 1313-1324. 7. Computational Simulations of HIV-1 Proteases-Multi-drug Resistance Due to Nonactive Site Mutation L90M, Ode, H.; Neya, S.; Hata, M.; Sugiura, W.; Hoshino, T., J. Am. Chem. Soc. 128, (2006), 7887-7895. 8. Drug discovery using grid technology, H. Goto, S. Obata, T. Kamakura, N. Nakayama, M. Sato, Y. Nakajima, U. Nagashima, T. Watanabe, Y. Inadomi, M. Ito, T. Nishikawa, T. Nakano, L. Nilsson, S. Tanaka, K. Fukuzawa, Y. Inagaki, M. Hamada, H. Chuman, in "Modern methods for theoretical physical chemistry of biopolymers", E. B. Starikov, J. P. Lewis, S. Tanaka, Eds., pp 227-248, Elsevier, Amsterdam, 2006. 9. Theoretical prediction of optical absorption maxima for photosensory receptor mutants, K. Kawaguchi, T. Yamato, Chem. Phys. Lett. 430 (2006) 386. 10. Aggregation mechanism of polyglutamine diseases revealed using quantum chemical calculations, fragment molecular orbital calculations, molecular dynamics simulations, and binding free energy calculations, K. Tsukamoto, H. Shimizu, T. Ishida, Y. Akiyama, N. Nukina, J. Mol. Str. (THEOCHEM) 778 (2006), 85-95. 11. Computational Analysis of the Proton Translocation from Asp96 to Schiff Base in Bacteriorhodopsin, Sato, Y.; Hata, M.; Neya, S.; Hoshino, T. J. Phys. Chem. B. (2006), 110, 22804-22812. 12 . T. Sakurai, Y. Kodaki, H. Tadano, H. Umeda, Y. Inadomi, T. Watanabe, U. Nagashima, A Master-Worker Type Eigensolver for Molecular Orbital Computations, in Lecture Notes in Computer Science, vol. 4699, Applied Parallel Computing. State of the Art in Scientific Computing, Springer Berlin, 2007, pp. 617-625. 13. M. Aoyagi, 2007, Grid Enabling of Nano-Science Applications in NAREGI, in IFIP International Federation for Information Processing, Volume 239, Grid-Based Problem Solving Environments, eds. Gaffney. P. W., Pool, J.C.T., (Boston: Springer), pp. 393-394. 14. The Predictive Accuracies of Spectroscopic Parameters in Biological Macromolecules by Fragment MO Method, Y. Sengoku, S. Miyahara, H. Wakabayashi H. Sekino, J. Comput. Aided Chem. 8 (2007) pp.85-91. 15. Evaluation of NMR Chemical Shift by Fragment Molecular Orbital Method, H. Sekino, N. Matsumura, Y. Sengoku, Comput. Lett. 3 (2007) 423-430. 16. Fragmentation position dependency of the total energy and atomic charge difference between the fragment MO method and conventional ab initio SCF-MO method. A case of (-)-epicatechin gallate with STO-3G basis set, K. Tamura, Y. Inadomi, U. Nagashima, Bull. Chem. Soc. Jpn. 80 (2007) 721-723. 17. Difference in the potential energy surfaces from the fragment MO method and conventional ab initio SCF-MO method. A case of a surface for ring rotation of (-)-epicatechin gallate using the STO-3G basis set, K. Tamura, T. Watanabe, T. Ishimoto, U. Nagashima, Bull. Chem. Soc. Jpn. 80, (2007) 1939-1941. 18. Ab initio MO-MD simulation based on the fragment MO method. A case of (-)-epicatechin gallate with STO-3G basis set, K. Tamura, T. Watanabe, T. Ishimoto, U. Nagashima, Bull. Chem. Soc. Jpn. 81 (2008), 110-112. 19. FMO-MO method as an initial guess generation for SCF calculation: Case of (-)-epicatechin gallate, K. Tamura, T. Watanabe, T. Ishimoto, H. Umeda, Y. Inadomi, U. Nagashima, Bull. Chem. Soc. Jpn. 81 (2008) 254-256. 20. Interaction of HIV-1 aspartic protease with its inhibitor, by molecular dynamics and ab initio fragment molecular orbital method, K. Koyano, T. Nakano, J. Synchr. Rad. 15 (2008) 239-242. 21. Binding Interaction Analysis of the Active Site and Its Inhibitors for Neuraminidase (N1 Subtype) of Human Influenza Virus by the Integration of Molecular Docking, FMO Calculation and 3D-QSAR CoMFA Modeling, Zhang, Q.; Yang, J.; Liang, K.; Feng, L.; Li, S.; Wan, J.; Xu, X.; Yang, G.; Liu, D.; Yang, S. J. Chem. Inf. Model 48 (2008) 1802-1812. 22. GridFMO - Quantum chemistry of proteins on the Grid. T. Ikegami, J. Maki, T. Takami, Y. Tanaka, M. Yokokawa, S. Sekiguchi, M. Aoyagi, Proc. 8th IEEE/ACM International Conference on Grid Computing, Austin, 2007, 50-57. 23. Multi-physics extension of OpenFMO framework. T. Takami, J. Maki, J. Ooba, Y. Inadomi, H. Honda, R. Susukita, K. Inoue, T. Kobayashi, R. Nogita, M. Aoyagi, Proc. International Conference on Computational Methods in Science and Engineering, Corfu, Greece, 2007, AIP Conf. Proc. Vol. 2, 122-125, Part A-B. 24. Ab initio FMO-MD method reimplemented and applied to pure water. Y. Komeiji, T. Ishikawa, Y. Mochizuki, H. Yamataka, T. Nakano, Proc. International Conference on Computational Methods in Science and Engineering, Corfu, Greece, 2007, AIP Conf. Proc. Vol. 2, 1261-1264, Part A-B. 25. Structural stability analysis of the intermediates in the folding pathway of human telomeric hybrid-1 G-quadruplex based on fragment molecular orbital method. H. Yagi, T. Mashimo, Y. Sannohe, H. Sugiyama, Nucl. Acids Symp. Ser. 52 (2008) 161-162. 26. Probing protein environment in an enzymatic process: all-electron quantum chemical analysis combined with ab initio quantum mechanical/molecular mechanical modeling of chorismate mutase. T. Ishida, J. Chem. Phys. 129 (2008) 125105. 27. Accurate Methods for Large Molecular Systems. M. S. Gordon, J. M. Mullin, S. R. Pruitt, L. B. Roskop, L. V. Slipchenko and J. A. Boatz, J. Phys. Chem. B 113 (2009) 9646-9663. 28. Ab initio base fragment molecular orbital studies of influenza viral hemagglutinin HA1 full-domains in complex with sialoside receptors. T. Sawada, T. Hashimoto, H. Tokiwa, T. Suzuki, H. Nakano, H. Ishida, M. Kiso, Y. Suzuki, J Mol Genet Med. 3 (2009) 133-142. 29. Theoretical study of hydration models of trivalent rare-earth ions using model core potentials. T. Fujiwara, H. Mori, Y. Mochizuki, H. Tatewaki, E. Miyoshi, J. Mol. Str. (THEOCHEM) 949 (2010) 28-35. 30. Effects of Point Mutation on Enzymatic Activity: Correlation between Protein Electronic Structure and Motion in Chorismate Mutase Reaction. T. Ishida, J. Am. Chem. Soc., 132 (2010) 7104-7118. 31. Effective Fragment Molecular Orbital Method: A Merger of the Effective Fragment Potential and Fragment Molecular Orbital Methods. C. Steinmann, D. G. Fedorov, J. H. Jensen, J. Phys. Chem. A 114 (2010) 8705-8712. 32. Ab initio fragment molecular orbital calculations on the specific interactions between human, mouse and rat PPARagr and GW409544. M. Hayakawa, T. Ohyama, Y. Yamaguchi, S. Iwabuchi, T. Nakagawa, T. Nakajima, N. Kurita. Mol. Sim. 36 (2010) 644-656. 33. Molecular tailoring approach in conjunction with MP2 and Ri-MP2 codes: A comparison with fragment molecular orbital method. A. P. Rahalkar, M. Katouda, S. R. Gadre, S. Nagase, J. Comp. Chem. 31 (2010) 2405-2418. 34. Folding Pathways of Human Telomeric Type-1 and Type-2 G-Quadruplex Structures. T. Mashimo, H. Yagi, Y. Sannohe, A. Rajendran, H. Sugiyama, J. Am. Chem. Soc. 132 (2010) 14910-14918. 35. Prediction of cyclin-dependent kinase 2 inhibitor potency using the fragment molecular orbital method. M. P. Mazanetz, O. Ichihara, R. J. Law, M. Whittaker, J. Cheminf. 3 (2011) 2. 36. Compound Design by Fragment-Linking. O. Ichihara, J. Barker, R. J. Law, M. Whittaker, Mol. Inf. 30 (2011) 298-306. 37. Book Review: The Fragment Molecular Orbital Method: Practical Applications to Large Molecular Systems. L. Massa, Int. J. Quantum Chem. 111 (2011) 3251. 38. Rational questing for potential novel inhibitors of FabK from Streptococcus pneumoniae by combining FMO calculation, CoMFA 3D-QSAR modeling and virtual screening. Q. Zhang, C. Yu, J. Min, Y. Wang, J. He, Z. Yu, J. Mol. Model. 17 (2011) 1483-1492. 39. Acceleration of a QM/MM-QMC simulation using GPU. Y. Uejima, T. Terashima, R. Maezono, J. Comp. Chem. 32 (2011) 2264-2272. 40. Large scale quantum chemical calculation for drug discovery. K. Kitaura, Yakugaku zasshi 131 (2011) 1163-1169. 41. Specific interactions and binding free energies between thermolysin and dipeptides: Molecular simulations combined with Ab initio molecular orbital and classical vibrational analysis. K. Dedachi, T. Hirakawa, S. Fujita, M. T. H. Khan, I. Sylte, N. Kurita, J. Comp. Chem. 32 (2011) 3047-3057. 42. Model for the fast estimation of basis set superposition error in biomolecular systems. J. C. Faver, Z. Zheng, K. M. Merz, Jr. J. Chem. Phys. 135, 144110 (2011). 43. Structure-based rational design of novel hit compounds for pyruvate dehydrogenase multienzyme complex E1 components from Escherichia coli. Y. Ren, J. He, L. Feng, X. Liao, J. Jin, Y. Li, Y. Cao, J. Wan, H. He, Bioorg. Med. Chem. 19 (2011) 7501-7506. 44. Fragmentation Methods: A Route to Accurate Calculations on Large Systems. M. S. Gordon, D. G. Fedorov, S. R. Pruitt, L. V. Slipchenko, Chem. Rev. 112 (2012) 632-672. 45. Structure and Dynamics of the 1-Hydroxyethyl-4-amino-1,2,4-triazolium Nitrate High-Energy Ionic Liquid System. P. J. Carlson, S. Bose, D. W. Armstrong, T. Hawkins, M. S. Gordon, J. W. Petrich, J. Phys. Chem. B 116 (2012) 503-512. 46. Discovery and Structure-Activity Relationship of Potent and Selective Covalent Inhibitors of Transglutaminase 2 for Huntingtons Disease. M. E. Prime, O. A. Andersen, J. J. Barker, M. A. Brooks, R. K. Y. Cheng, I. Toogood-Johnson, S. M. Courtney, F. A. Brookfield, C. J. Yarnold, R. W. Marston, P. D. Johnson, S. F. Johnsen, J. J. Palfrey, D. Vaidya, S. Erfan, O. Ichihara, B. Felicetti, S. Palan, A. Pedret-Dunn, S. Schaertl, I. Sternberger, A. Ebneth, A. Scheel, D. Winkler, L. Toledo-Sherman, M. Beconi, D. Macdonald, I. Munoz-Sanjuan, C. Dominguez, J. Wityak, J. Med. Chem. 2012, 55, 1021-1046.